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ABSTRACT
Objective: Since its birth about 30 years ago,
Narrative Medicine approach has increased in
popularity in the medical context as well as in other
disciplines. This paper aims to review Narrative
Medicine research studies on patients’ and their
caregivers’ illness experience.
Setting and participants: MEDLINE, Psycinfo,
EBSCO Psychological and Behavioural Science, The
Cochrane Library and CINAHL databases were searched
to identify all the research studies which focused on
the Narrative Medicine approach reported in the title, in
the abstract and in the keywords the words ‘Narrative
Medicine’ or ‘Narrative-based Medicine’. Primary and
secondary outcome measures: number of participants,
type of disease, race and age of participants, type of
study, dependent variables, intervention methods,
assessment.
Results: Of the 325 titles screened, we identified 10
research articles fitting the inclusion criteria. Our
systematic review showed that research on Narrative
Medicine has no common specific methodology:
narrative in Medicine is used as an intervention
protocol as well as an assessment tool. Patients’
characteristics, types of disease and data analysis
procedures differ among the screened studies.
Conclusions: Narrative Medicine research in medical
practice needs to find clear and specific protocols to
deepen the impact of narrative on medical practice and
on patients’ lives.
INTRODUCTION
Narrative Medicine (or Narrative-Based
Medicine) has developed as a theoretical
and operative approach which has been
increasingly discussed in recent years. This
approach first came into existence about
30 years ago,1 and aims to introduce into
daily medical practice the use of narrative as
a tool to collect and interpret information
on the patient’s experience of illness.2 As
Trisha Greenhalgh wrote (p. 318): ‘Clinical
method is an interpretive act which draws on
narrative skills to integrate the overlapping
stories told by patients, clinicians and test
results’. Nevertheless, the current debate is
focused more on the dualism between
Narrative Medicine and Evidence-Based
Medicine:3 on the one hand medicine needs
to be focused on scientifically-rigorous trials
and to follow specific protocols, on the other
hand the final aim of medical practice is
always related to what a patient feels, what
they perceive they feel and above all, what
they say they feel. What scholars have
pointed out is that listening to the patient’s
story is a tool to enrich not only the knowl-
edge of their physical and psychological con-
dition, but also to offer information with
which to formulate the diagnosis.2 4–6 Thus,
physicians and health staff need in their daily
practice would seem to be to adopt a
‘Narrative Evidence-Based Medicine’.7
In this sense, numerous teaching pro-
grammes in Narrative Medicine have recently
been created (see http://ce.columbia.edu/
narrative-medicine or https://www.kcl.ac.uk/
prospectus/graduate/medical-humanities) to
increase narrative competences of the health
staff and to teach them how to use them in
their daily work. Some studies have investi-
gated the role of Narrative Medicine in
teaching communication skills and increas-
ing personal variables in health staff.8 9
Furthermore, experts in the field of
Narrative Medicine argue that this approach
Strengths and limitations of this study
▪ The manuscript proposes a first review of
research studies in medicine conducted with a
Narrative Medicine methodology.
▪ A systematic analysis was conducted to review
scientific evidence in the field starting from the
first publication on Narrative Medicine.
▪ Owing to the narrative nature of data, it was not
possible to implement a meta-analysis of the
selected studies.
Fioretti C, et al. BMJ Open 2016;6:e011220. doi:10.1136/bmjopen-2016-011220 1
Open Access Research
 o
n
 2 August 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2016-011220 on 14 July 2016. Downloaded from 
also plays something of a therapeutic role for patients.10
Thus, adopting a Narrative Medicine procedure in
medical practice has positive consequences for the
person who experiences a disease. In this case, the
meaning of Narrative Medicine seems to be that of
accompanying the patient through the listening of her/
his story of illness. Many authors such as Bury,11 have
suggested that any illness constitutes a disruption, a sort
of discontinuance of an ongoing life. Lifespan psycholo-
gists and developmental psychologists have stressed the
importance of considering illness as a non-normative
transition of life which requests the individual to work
towards the re-establishment of the normative life
balance. When a person faces a chronic illness, the need
to reconstruct their life story connecting the past life
with the present experience of illness is strong. In this
particular context, narrative becomes an opportunity to
give voice to the disruption and to provide it within a
time framework12 not separated from the other life
events which form part of the individual’s autobio-
graphical story. There are many examples of the use of
narrative to the repair life disruption due to illness.
Anatole Broyard, a renowned essayist of the New York
Times, who in his pathography reconstructed the story
of his illness, famously affirmed that ‘storytelling seems
to be a natural reaction to illness. People bleed stories,
and I’ve become a blood bank of them’.13
In this domain, adopting a narrative-based approach
could be a valid tool whereby patients are helped to
re-elaborate their experience. Nevertheless, scientific
studies on the effectiveness of Narrative Medicine and
the evidence regarding its use in daily practice with
patients have not been reviewed so far.
This work aims to provide a systematic review of the
research studies based on a Narrative Medicine
approach conducted with patients and/or with their
caregivers. Thus, it aims to clarify the scientific evidence
in the literature concerning the role of Narrative
Medicine in patients’ experience of illness. Despite the
importance that Narrative Medicine approach is acquir-
ing in biomedical and health sciences, just a few studies
have tried to underline the scientific value of this
approach. Nevertheless, many studies have underlined
the effect of narrative intervention in medicine. Zhou
et al14 for example, reviewed the randomised controlled
trials assessing the effect of expressive writing interven-
tion (EWI)15 on health outcomes in patients with breast
cancer. This kind of intervention, asking participants to
reflect in a written format about negative past life
events, aims to improve emotional expression and elab-
oration of stressful situations improving psychological
and physical health. Comparing 11 articles, they found
that EWI has a significant effect on reducing the nega-
tive somatic symptoms in a 1 to 3-month follow-up.
At the same time, Frisina et al16 explored the effects of
the written Emotional Disclosure paradigm on the
health outcomes of people with physical or psychiatric
disorders. Meta-analysing nine articles, they found that
expressive writing significantly improves health, but is
more effective on physical than on psychological health
outcomes.
Studies on the effectiveness of narrative methods with
patients have not focused solely on the expressive
writing paradigm. For instance, Chocinov et al17 imple-
mented a dignity therapy intervention with patients near
the end of life. Asking patients to write a novel discuss-
ing issues of their life story or those that they would
most want remembered, they found in a test–retest
design a significant improvement of sense of dignity and
a reduction of depression symptoms and sense of
suffering.
Furthermore, Houston et al18 assessed the use of story-
telling as an intervention to improve blood pressure. In
a randomised trial study, they randomly divided patients
suffering from hypertension, using in the experimental
group DVDs containing patient stories and measuring
the blood pressure 3, 6 and 9 months after the interven-
tion. They found that the storytelling intervention pro-
duced substantial and significant improvements in blood
pressure for patients with baseline uncontrolled
hypertension.18
Nevertheless, none of these studies considered their
interventions based on narrative as part of the Narrative
Medicine approach. Although the procedures were
based on the implementation of narrative methods in
medicine, authors did not refer to Narrative Medicine in
their articles.
Since our aim was to review the role of studies on the
Narrative Medicine approach itself, this review took into
consideration just those research studies that reported in
the title, in the abstract section or in the keywords the
phrase Narrative Medicine (or Narrative-Based
Medicine). In extracting data and organising the review,
we referred to the PRISMA Statement for the reporting
of systematic reviews and meta-analyses.19
MATERIALS AND METHODS
To find the most relevant articles for the systematic
review, we searched main databases without restriction
of language. We limited our search to begin from 1988,
the year in which Kleinmann1 published his first work
on illness narratives. PubMed, PsycINFO, CINAHL,
EBSCO Psychological and Behavioural Science and the
Cochrane Library were employed. We did not manually
search conference proceeding or dissertations, due to
limitations of time and resources. To select the most
relevant works, we considered just the studies that met at
least one of the following criteria: (1) articles that
reported the words ‘Narrative Medicine’ or
‘Narrative-Based Medicine’ in the title, in the abstract
and/or in the keywords; (2) research studies, empirical
or case study articles referring to the Narrative Medicine
approach in the background and/or methodological
section. This second criterion was due to the need to
separate Narrative Medicine studies from studies using
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narrative methods that were not considered by authors
as works about Narrative Medicine.16 14 (3) Research
studies focused on patients or caregivers’ samples. After
an initial literature review, the authors decided to
include in the review process both intervention pro-
grammes using a Narrative Medicine approach and
research studies using it as a tool to explore patient’s
experience of illness.
Two authors explored the scientific literature and inde-
pendently extracted the data from every selected article.
See table 1 for a summary of the search strategies and
sources for the review implementation. As an example, for
the PubMed database the used search string was:
((Narrative Medicine[Title/Abstract)) OR Narrative based
Medicine(Title/Abstract)) AND (“1988”(Date—
Publication): “3000”(Date—Publication)).
The general information (name of the authors and
year of publication), as well as the study characteristics
(type of study, dependent variables) and the participants
characteristics (sample, disease, race, mean age of parti-
cipants) were extracted (see table 2). Since some of the
selected articles reported interventions using a Narrative
Medicine approach, we also extracted the intervention
procedures as a variable of the review. When data were
missing in the articles, we coded such data as not
reported. Since Narrative Medicine is not only a theoret-
ical but also a methodological approach providing clini-
cians and researchers with an intervention tool in their
daily activity with patients, authors assessed and graded
the quality of included studies focusing on their meth-
odological design and on the dependent variables
investigated.
RESULTS
Search results
The electronic literature search of articles was con-
ducted in September 2015. Overall, a total of 325
abstracts and titles were analysed, identifying 70 dupli-
cates. Of the 255 titles and abstracts, 228 were excluded
due to irrelevancy (n=86) or because they were reviews,
theoretical or critical articles, editorials or book reviews
(n=142). The remaining 27 full-text articles were exam-
ined to identify whether the studies were in line with all
the inclusion criteria. Seventeen articles were excluded
if they described intervention projects or research
studies conducted with professional staff. After having
checked the reference lists of the selected full-texts, no
additional items were found. Figure 1 illustrates the flow
diagram of the present review.
Included studies
Ten studies considering the patients illness experience
through a Narrative Medicine approach were included
in the systematic review. All the studies are presented
and described in table 2.
Overall, a total amount of 1021 participants were
involved in the considered studies. Of these, 687 were
patients and 334 were caregivers. A total of 155 patients
participated in a randomised controlled trial as part of
control group (n=78) or experimental group without
Narrative Medicine intervention (n=77). The majority of
the participants were adults, while 50 of them were
children.
Considering the type of disease experienced by the
participants, three studies involved the participation of
patients with cancer; the others explored
Pelizaeus-Merzbacher Disease, the experience of being
pregnant after liver transplantation, diabetes, mental
illness (bipolar disorder), fertility problems and assisted
reproduction treatment. Two studies did not report the
participants’ type of disease, but in one of these two,
authors reported that the participants had been con-
tacted in the intensive care unit of a hospital.
Table 1 Summary of search and source for the implementation review
Component Description, inclusion/exclusion criteria and process of data extraction
Population We included studies focused on patients’ and/or caregivers’ samples. Since scientific literature
reported the use of a Narrative Medicine approach in every type of disease, we included in the
review all the studies that considered patients affected by every kind of physical and mental illness.
No restriction of race, age or other sample characteristics was considered.
Study design/type of
study
Different types of study designs were considered, both research studies and intervention studies.
Since studies adopting narrative methods are usually implemented with small size samples, we also
included case studies in the review.
We also selected studies considered by their own authors as part of the Narrative Medicine
approach.
Dependent variables Owing to the characteristics of the checked articles, we included in the review research studies
exploring different types of variables such as pain or well-being, satisfaction in participating in the
intervention and structure of illness narratives.
Databases PubMed (186 records), CINAHL (69 records), EBSCO Psychological and Behavioural Science (30
records), The Cochrane Library (15 items) and PSYCINFO (25 items). Authors closely examined the
bibliographies of the full-text screened articles to identify any additional possible study
Other exclusion criteria Dissertations, book reviews and editorials were not considered.
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Table 2 Characteristics of the included studies
Reference
(year) Sample Disease Race
Mean
age
(SD) Type of study
Dependent
variables Intervention methods Assessment
Cepeda
et al20
(2008)
234 patients Cancer NR 48.5
(12.4)
Randomised trial Pain and well-being
perception
20 min narrative session
one time per week for
3 weeks
Pain 0–10 scale
and well-being
Likert scale
Cotichelli25
(2012)
2 caregivers Pelizaeus-Merzbacher
Disease (rare)
NR NR Case study Perception of
sociorelational
quality of service
NO Analysis of
categories emerged
in narratives
Di Gangi
et al26
(2013)
332
caregivers;
258 patients
NR (intensive care unit) NR NR Retrospective
observational
Patients’ and
caregivers’ lives
information derived
from diary guest
books
NO Cluster analysis
with the software R
Word Cloud 2.0
package
Donzelli
et al27
(2015)
3 patients Pregnant after liver
transplantation
NR NR Exploratory Role of narrative
medicine in facing
illness experience
NO Narrative analysis
of the collected text
Esquibel and
Borkan28
(2014)
21 patients NR NR NR Exploratory Chronic non-cancer
pain
NO Thematic analysis
of in depth narrative
interview
Greenhalgh
et al21
(2005)
NR Diabetes Asian NR Action-research Learning on
diabetes disease
and change in
behaviour
Storytelling groups with
patients on their
experiences of disease
Observation of
patients behaviour
Massimo
and Zarri22
(2006)
50 patients Paediatric leukaemia or
cancer
8 (NR) Children’s
perception of the
disease
Drawing therapy in
hospital
Observation of
children’s behaviour
Michalak
et al23
(2014)
80 patients Mental illness (bipolar
disorder)
Caucasian
(83% of
participants)
42.4
(12.2)
Mixed methods
design
(prospective,
longitudinal)
Perception of
Internalised stigma
Theatre class and
performance.6 weeks of
4-hour meetings, 3–4
times per week
1. Day’s Mental
Illness Stigma
Scale;
2. Internalised
Stigma of Mental
Illness Scale;
3. Theatric
performance
evaluation
Smorti and
Smorti29
(2013)
30 patients Fertility problems/
assisted reproduction
treatment
Caucasian 37
(4.3)
Exploratory Couple’s
psychological
problems due to
pregnancy via ART
NO Narrative analysis
of common threads
and phases of the
parenthood
transition
Continued
4
FiorettiC,etal.BM
J
Open
2016;6:e011220.doi:10.1136/bm
jopen-2016-011220
O
p
e
n
A
c
c
e
s
s
 on 2 August 2019 by guest. Protected by copyright. http://bmjopen.bmj.com/ BMJ Open: first published as 10.1136/bmjopen-2016-011220 on 14 July 2016. Downloaded from 
Of the 10 studies, four described the individuals’ race.
In three studies, Caucasian patients participated in the
research, in one case the study was conducted with the
participation of Asian patients. The mean age was
reported in five studies.
Considering the type of study conducted, the results
of systematic analysis underline different designs: four
exploratory studies, one case study, one randomised
trial, one action research, one retrospective observa-
tional study and one mixed methods design (prospect-
ive and longitudinal).
As mentioned above, the review includes both studies
using Narrative Medicine as an intervention and studies
using Narrative Medicine as a tool for collecting data.
Of the 10 studies examined, five were intervention
studies using Narrative Medicine procedures as an assess-
ment tool. In those cases, the intervention procedures
differed greatly among the studies.
Cepeda et al20 performed a randomised controlled
trial in adult patients with cancer assessing whether
using a Narrative Medicine approach decreases pain
intensity and improves the global sense of well-being.
They divided the patients into three groups: the first
(experimental group) wrote a story three times—once a
week—for at least 20 min, about how cancer affectedT
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Figure 1 Research studies on patients and caregivers
conducted with the Narrative Medicine approach (2005/2015).
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their lives; the second (attention group) completed a
questionnaire on pain; the third (control group)
attended weekly medical follow-up visits to receive the
usual care provided for their therapies. Overall, results
showed that the three groups did not differ in pain
intensity and well-being in the follow-up assessment.
Nevertheless, patients who showed more emotional dis-
closure in narratives experienced significantly less pain
and reported higher well-being scores than patients who
wrote a narrative with a lower emotional disclosure.
Greenhalgh et al21 used the Narrative Medicine
approach as an intervention to promote learning about
diabetes and behavioural change in Asian patients with
diabetes. In an initial phase, researchers developed
storytelling training in a group of bilingual health advo-
cates (BHAs). They then implemented a research activ-
ity in which trained BHAs set up storytelling groups for
patients. Even though the study did not formally test the
impact of the storytelling group on patients’ blood
glucose control or other psychological or medical vari-
ables, authors argued that after the intervention,
patients reported being more confident and more active
with respect to their illness.
Massimo and Zarri22 performed an intervention on
children suffering from cancer or leukaemia focused on
drawing therapy and aimed at reducing their stressful
response to hospitalisation and the dramatic changes in
their lives. They collected both spontaneous and soli-
cited drawings asking children ‘can you draw me a
picture?’ and later asking them to tell a brief story in
their drawing. To assess patients’ change, they observed
drawings and children’s behaviours and evaluated differ-
ences in the illness representation and in the subject of
the drawings which emerged. Results underlined that
the attention the children received made them more
willing to cooperate, showing less stressful response to
the hospitalisation and disease therapies.
Michalak et al23 used theatre to address mental illness
stigma in people with bipolar disorder. In a longitudinal
study, they involved participants in theatre performance
assessing stigma measures once before the intervention
and twice after it (immediately and at follow-up 3–4
months later). The follow-up data collection also
included an interview to elicit in depth conversation of
the participants’ perceptions of the impact of the play
on their mental stigma. The intervention consisted of
six meetings of 4 h each, conducted three to four times
per week and a final play with a 30 min question time.
The intervention also involved the participation of 84
healthcare providers. Since the aim of this review is to
assess research studies and intervention on patients and
caregivers, we will not consider the results of this inter-
vention concerning the health staff. Overall, patients
with bipolar disorders showed a small quantitative
change in mental stigma measures, with a significant
decrease in the subscale of feelings of alienation imme-
diately after the performance but not in the follow-up.
Conversely, comparing quantitative data with the
collected qualitative interviews, results showed that indi-
viduals expressed continuous positive effects from the
intervention.
Wise et al24 implemented an online narrative educa-
tion programme for 11 patients with cancer combining
three types of intervention to help patients address emo-
tional and existential issues. The intervention was com-
posed of: (1) a telephone interview to elicit the life
narrative; (2) a life review education with the final
editing of a manuscript; (3) a website giving instruc-
tional materials and consultation to help people revising
and sharing their story. The intervention effects were
assessed through in depth exit interviews. Results
showed that patients benefited from the intervention
appreciating the opportunity to capture their story and
to engage families in its editing.
The other four studies included in the review used
Narrative Medicine as part of the research methodology
implemented to evaluate different dependent variables.
Cotichelli25 presented qualitative research published
in an Italian journal using Narrative Medicine to evalu-
ate the perception of sociorelational quality of the
health service in two parents of a family facing a rare
paediatric disease. Interviewing the two caregivers and
implementing a thematic analysis, the author found the
following dimensions: a complex clinical context bur-
dening children and parents, the initial scarcity of
helpful assistance and a close friendship network, the
limitations of the sociosanitary services in diagnosing
rare diseases and caring for children suffering for those
pathologies, the individual role of single professionals in
providing support to the families, the creation—in a fol-
lowing phase—of a support network, with a special role
of the voluntary associations.
Di Gangi et al26 explored the informative role of
diaries and guest books in a narrative-based study. From
2009 and 2011 they collected stories spontaneously
written by patients and caregivers attending the intensive
care unit and implemented a software-based cluster ana-
lysis to identify the main themes. Results underlined that
stories were frequently written in the form of a letter to
patients to encourage them or to show emotional
release. Diaries have been also used to provide feedback
for the staff.
Donzelli et al27 explored the experience of pregnancy
after liver transplantation using a Narrative Medicine
tool approach. They conducted interviews and listened
to the stories of three women who become pregnant
after a liver transplantation, then they transcribed and
analysed the narrative plot to extrapolate the emerging
themes. Three phases of the experience of illness were
identified: (1) the transplant, in which the mothers felt
the need to talk about their operation; (2) the preg-
nancy and the delivery, in which the mothers individu-
ated the discovery of the pregnancy as the most delicate
moment of their lives; finally the (3) postpartum, in
which the main protagonist of the story of disease is the
child and a new prospect for the future.
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Esquibel and Bokran28 explored the ways in which
chronic pain and opioid medication influence the
doctor–patient relationship. To collect narratives they
used an in depth interview with a semistructured guide
and open-ended questions. Researchers also interviewed
patients’ physicians, but these results were not consid-
ered for the present review. The analysis of collected
narratives revealed that patients focused their stories on
suffering for chronic pain and on the role of opioid
therapy to provide relief. The authors concluded
arguing that the use of narrative to explore chronic pain
has significant implications for improving the doctor–
patient relationship.
Smorti and Smorti29 used a Narrative-based Medicine
approach to investigate medical success and couples’
psychological problems in assisted reproduction treat-
ment. They administered face-to-face semistructured
autobiographical interviews to couples in order to
explore the story of the pregnancy in depth, transcribing
the interviews verbatim and analysing them via a the-
matic analysis. Results showed that assisted reproduction
treatment leads to a very stressful experience and is nar-
rated by couples through a plot consisting of four
phases: doubt, final sentence, victory and monitoring.
A final characteristic considered by the present review
is the assessment procedure of the included studies. In
this case, the review underlines that five studies assessed
the dependent variables conducting narrative analysis of
the collected texts. Among them, one study26 implemen-
ted a text analysis software; the other authors carried out
a thematic, plot or narrative analysis.
Two studies assessed dependent variables using a
Likert scale or self-report questionnaires: they conducted
a quantitative and statistical analysis of the collected
data.
Two studies used observation of patients’ behaviour to
assess changes in perception of disease and learning
about disease management. Finally, Wise et al24 assessed
the benefit from an autobiographical storytelling inter-
vention through an in depth interview.
DISCUSSION
The main aim of the present work was that of reviewing
the research/intervention studies adopting a Narrative
Medicine approach with patients and caregivers. Overall,
10 studies were included in the review. The main results
emerged provide evidence that Narrative Medicine is a
useful tool to assess the patients’ experience of illness
and could be implemented in daily medical practice to
enrich general clinical information focused on the
needs and the critical aspects of patients’ lives. This in
turn could affect the normal therapeutic pathway.
Furthermore, Narrative Medicine also seems to be a
powerful instrument for decreasing pain and increasing
well-being related to illness (when patients’ narratives
show high emotional disclosure), for being more confi-
dent, active and cooperative in respect to the illness, for
having a less stressful response and decreasing feelings
of alienation and finally for sharing illness stories with
family members.
Although the debate within the Narrative Medicine
approach was started some 30 years ago, a systematic
review shows that the majority of scientific literature in
the field is still composed of theoretical articles or crit-
ical reviews. Furthermore, all the studies included in the
review were conducted in the past 10 years. These data
stress the need for implementing more studies on the
effects and the power of Narrative Medicine on patients’
experience of illness.
Particularly, data collection underlines continuity
among studies on Narrative Medicine and studies on
other theoretical approaches such as Expressive
Writing/Emotional Disclosure paradigm and Dignity
Therapy in palliative care. All these studies use the story-
telling as a tool to help patients to express their feelings,
worries and doubts about the disease. It is interesting to
note, for instance, the similarity between the study of
Michalak et al23 on the use of theatre to address the
stigma of mental illness and the study of Roberts et al30
on an intervention programme in adolescents and
young adults based on applied drama and theatrical per-
formance. Both studies demonstrated the role of theatre
in decreasing mental stigma, even though the first
focused on patients with bipolar disorder adult23 and
the second on early psychosis in adolescence and emer-
ging adulthood.30 Nevertheless, Roberts et al did not rec-
ognise their work as a Narrative Medicine study.
As we mentioned earlier, there are also many similar-
ities among Narrative Medicine and emotional disclos-
ure/expressive writing interventions. The study of
Cepeda et al20 for instance, adopted an intervention
focused on emotional disclosure through writing once a
week for 3 weeks, about doubts, fears and feelings
related to the disease. This intervention seems to be very
similar to studies reviewed by Smith31 on written emo-
tional expression, although the latter did not refer in his
review to a Narrative Medicine approach.
In this sense, it seems very opportune to define the
boundaries of the Narrative Medicine approach in order
to give it a scientific independence and common proto-
cols to implement. Another important topic that
emerged from the review is that studies on Narrative
Medicine have used this approach both as an interven-
tion and as a tool to collect narrative data. From our
point of view, these two different types of Narrative
Medicine studies also imply different research goals.
The intervention studies included in the present
review were focused on the use of Narrative Medicine to
collect information on the effectiveness of this approach
and on the patient benefits derived from it. In this
sense, the main aim of the intervention studies on
Narrative Medicine seems to be that of assessing the effi-
cacy of the use of the approach on patients: data col-
lected would be evidence to spur health staff into using
it in their daily practice.
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If instead we look at studies which underline Narrative
Medicine as an instrument for collecting narrative data
we see that these aim to stress the importance of the
approach for providing qualitative information on the
patient’s experience of illness experience to the health
staff. Thus, the data collected would provide practical
knowledge to take into account in medical practice. For
instance, physicians caring for women who have under-
gone transplantation should take into consideration that
the discovery of the pregnancy is a very delicate moment
in their patients’ lives and calls for particular attention
to, and organisation of, healthcare.27 Greenhalgh and
Hurwitz,5 in fact, argued that ‘narratives offer a method
for addressing existential qualities such as inner hurt,
despair, hope, grief, and moral pain which frequently
accompany, and may even constitute, people’s illnesses’
(p. 318).
Considering the procedural limitations of reviewed
works, the systematic review has shown that studies have
engaged the participation of very different samples for
size, patients’ main age and type of disease. Considering
that every disease has its own individual care path and
thus is associated with different physical and psycho-
logical experiences, depending on patients’ character-
istics, it seems opportune to take into account the
individual disease in the design planning of Narrative
Medicine studies with patients. More information on the
type of disease and the sample characteristics should be
addressed in future studies.
Furthermore, intervention studies overall did not
report the integration of control groups in their
research design. Except for the randomised trial con-
ducted by Cepeda et al20 all other studies have investi-
gated the role of Narrative Medicine interventions
without comparing them with other interventions or
control groups. Also, the nature of the intervention
greatly varies. Participants in the studies included in the
review have performed on telephone autobiographical
interviews, manuscript editing, theatre performance,
drawing, storytelling groups and 20 min narrative
sections.
Another limitation is the high variety of data coding of
narratives collected in the research studies using
Narrative Medicine as a tool for collecting patients’
experiences. In one case26 researches implemented a
software of textual analysis assessing the emerged clus-
ters of narratives, in the other studies authors preferred
to conduct a thematic, plot or narrative analysis.
To conclude, it seems very suitable to define the
boundaries of the Narrative Medicine approach when it
is used in research with patients in order to give it scien-
tific independence and common protocols to imple-
ment. Thus, intervention programmes should be
compliant with the theoretical framework, as well as the
analysis of patients’ experiences collected through a
Narrative Medicine approach. Starting from the copious
scientific literature on the topic, researchers should find
a common methodology and a shared procedure which
will give the opportunity to replicate the study in other
contexts and with patients suffering from different
diseases.32–35
In 2014 in Rome, a committee of international experts
in the field participated in a Consensus Conference on
recommendations for the implementation of Narrative
Medicine in clinical practice.36 The committee declared
to define Narrative Medicine as a methodology of clin-
ical intervention based on a specific communicative
competence. Narrative has also defined as a fundamen-
tal tool to acquire, comprehend and integrate the differ-
ent points of view of all the participants having a role in
the illness experience. In this sense, the main aim of the
Narrative Medicine approach would be that of
co-construct a shared and personalised care path.36
Authors agree with the cited definition and recognise
the important role of considering Narrative Medicine as
a tool for clinicians daily practice and communication
with their patients. In this sense, Narrative Medicine has
to be considered as a part of a new broader culture
change stressing the importance of humanisation of the
care and a personalised Medicine37 38 tailored and con-
structed on the individual experience,39 story and needs
of every patient.
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